Search

everythinglearnresearchcommunity

for

Search:↓

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Hair loss treatment caused more hair loss in a man.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

New cytokine-targeted therapies show promise for treating alopecia areata.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Certain gene variations may increase the risk and severity of alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Oxidative stress is important in causing alopecia areata.

CT60 polymorphism might increase the risk of Alopecia Areata.

A man had both alopecia areata and lichen planus, which is uncommon.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.